| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Axenio AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.50 |
| 52 Week High | €2.50 |
| 52 Week Low | €2.50 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 0% |
| 5 Year Change | n/a |
| Change since IPO | 56.25% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MK3 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.6% | 1.2% |
| 1Y | 0% | -3.9% | 2.0% |
Return vs Industry: MK3 exceeded the German Healthcare industry which returned -1.1% over the past year.
Return vs Market: MK3 exceeded the German Market which returned -1.2% over the past year.
Price Volatility
| MK3 volatility | |
|---|---|
| MK3 Average Weekly Movement | 0% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: MK3 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MK3's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.axenio.com |
Hande Health AG provides corporate consulting services for the healthcare sector. It focuses on corporate structure consulting and corporate research; the acquisition, sale, rental, and management of real estate; and the acquisition, management, and sale of assets. Hande Health AG was formerly known as Mandarin Capital AG.
Axenio AG Fundamentals Summary
| MK3 fundamental statistics | |
|---|---|
| Market cap | €1.00m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MK3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MK3 income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MK3 perform over the long term?
See historical performance and comparison